Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Trial Profile

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Feb 2014

At a glance

  • Drugs Febuxostat; Lesinurad
  • Indications Gout
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
    • 09 Nov 2010 New trial record
    • 08 Nov 2010 Results reported in an Ardea Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top